| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA545565
Max Phase: Preclinical
Molecular Formula: C13H14ClF3N4O
Molecular Weight: 298.27
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cl.O=C(NCCCn1cncn1)c1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C13H13F3N4O.ClH/c14-13(15,16)11-4-1-3-10(7-11)12(21)18-5-2-6-20-9-17-8-19-20;/h1,3-4,7-9H,2,5-6H2,(H,18,21);1H
Standard InChI Key: YYRKFZWQPJCFHF-UHFFFAOYSA-N
Associated Targets(non-human)
Thromboxane-A synthase 658 Activities
Rattus norvegicus 775804 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 298.27 | Molecular Weight (Monoisotopic): 298.1041 | AlogP: 2.12 | #Rotatable Bonds: 5 |
| Polar Surface Area: 59.81 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 2.29 | CX LogP: 1.53 | CX LogD: 1.53 |
| Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.86 | Np Likeness Score: -2.27 |
References
| 1. Wright WB, Press JB, Chan PS, Marsico JW, Haug MF, Lucas J, Tauber J, Tomcufcik AS.. (1986) Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides., 29 (4): [PMID:3959030] [10.1021/jm00154a017] |
Source
Source(1):